Bio-Techne Corporation
TECH
$54.41
$1.492.82%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -17.68M | 22.59M | 34.89M | 33.60M | 40.59M |
Total Depreciation and Amortization | -16.89M | 27.57M | 27.08M | 28.14M | -18.54M |
Total Amortization of Deferred Charges | 44.00M | -- | -- | -- | 46.60M |
Total Other Non-Cash Items | 67.20M | 3.45M | 10.18M | 11.89M | 17.09M |
Change in Net Operating Assets | 21.57M | -12.49M | 12.20M | -9.74M | -10.24M |
Cash from Operations | 98.20M | 41.12M | 84.35M | 63.89M | 75.50M |
Capital Expenditure | -4.89M | -10.12M | -6.82M | -9.17M | -17.98M |
Sale of Property, Plant, and Equipment | 658.00K | 0.00 | 1.79M | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | 0.00 |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 4.64M | 1.25M | 0.00 | -12.51M | 9.17M |
Cash from Investing | 406.00K | -8.87M | -5.03M | -21.68M | -8.81M |
Total Debt Issued | 66.00M | 38.00M | -- | -- | 0.00 |
Total Debt Repaid | -50.00M | -8.00M | 0.00 | -19.00M | -70.00M |
Issuance of Common Stock | 6.23M | 14.87M | 5.54M | 25.10M | 22.93M |
Repurchase of Common Stock | -100.29M | -100.34M | -76.64M | -4.98M | -402.00K |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -12.39M | -12.58M | -12.74M | -12.69M | -12.63M |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -90.45M | -68.05M | -83.84M | -11.57M | -60.10M |
Foreign Exchange rate Adjustments | 13.36M | -1.08M | -5.47M | 5.12M | 5.28M |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 21.52M | -36.88M | -9.99M | 35.75M | 11.88M |